Bristol Myers Squibb reports $13.07 billion revenue for quarter ended September 30, 2026, up 6.9%
Bristol Myers Squibb reported revenue of $13.07 billion for the quarter ended September 30, 2026, an increase of 6.9% from the same quarter a year earlier ($12.22 billion).
For the same period it posted net income of $2.16 billion, down 1.8%, or $1.05 per diluted share (1.08 a year earlier).
That is a net margin of 16.5%.
On Sanad's AAOIFI Standard 21 screen, Bristol Myers Squibb is currently not compliant: interest-bearing debt is 34.8% of market capitalisation (limit 30%), and impure income is 1.2% of revenue (limit 5%).
Is Bristol Myers Squibb halal?
See the full AAOIFI screening of Bristol Myers Squibb
See the full AAOIFI screening of Bristol Myers Squibb
Source: 10-Q filed with the U.S. Securities and Exchange Commission on October 29, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.